日本語View as Markdown

Hydrogen-rich saline protects immunocytes from radiation-induced apoptosis.

水素富化生理食塩水による放射線誘発免疫細胞アポトーシスへの防護効果

animal study injection / infusion positive

Abstract

This study examined whether hydrogen-rich saline and medium could protect immune cells from ionizing radiation (IR)-induced damage. In AHH-1 cells, pretreatment with hydrogen-rich medium significantly lowered intracellular hydroxyl radical (•OH) levels as measured by HPF probe. In mouse models, radiation-induced apoptosis in thymocytes and splenocytes was reduced following hydrogen administration, and caspase 3 activation was correspondingly suppressed. Hematological analysis further revealed that radiation-caused reductions in white blood cell and platelet counts were partially restored in hydrogen-treated animals. These findings indicate that molecular hydrogen can mitigate IR-induced immune system damage through free radical scavenging and anti-apoptotic mechanisms.

Mechanism

Molecular hydrogen scavenges hydroxyl radicals (•OH), thereby suppressing caspase 3 activation and reducing radiation-induced apoptosis in thymocytes, splenocytes, and circulating immune cells.

Bibliographic

Authors
Yang Y, Li B, Liu C, Chuai Y, Lei J, Gao F, et al.
Journal
Med Sci Monit
Year
2012
PMID
22460088
DOI
10.12659/msm.882616
PMC
PMC3560832

Tags

Disease:がん放射線療法 (副作用軽減) Mechanism:アポトーシス抑制 ヒドロキシルラジカル消去 免疫調節 炎症抑制 酸化ストレス 活性酸素種

Delivery context

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

Safety notes

Intravenous hydrogen-saline infusion is a clinic-only route and is not viable for everyday self-administration. For routine hydrogen intake, inhalation is the most practical route, but inhalation carries explosion risk and concentration matters (empirical LFL of 10%; high-concentration 66% / 100% devices are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 22460088. https://h2-papers.org/en/papers/22460088
Source: PubMed PMID 22460088